In a small study, intravenous mistletoe extract shows promise as a therapy for patients with advanced and treatment-resistant cancers.

Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.

Fake seeds can cost farmers more than two-thirds of expected crop yields and threaten food security. Trackable silk labels could help.

Studies show that smoking marijuana during pregnancy can lead to premature birth, lower birth weight and psychological problems in the newborn.

Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.

Sam Wattrus ’16, Ph.D. ’22, becomes the first human developmental and regenerative biology concentrator to establish an independent research lab.

On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.

High-quality bus service is the fastest route to rapid, comprehensive public transit in the United States. This country was once a leader in bus transit, and with adequate funding, it could be again.

MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.

Extracts from the flowers of two common wild plants block the virus that causes COVID from entering human cells.